LIN ELIZABETH YEU sold 70.8% of their position (11.58K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $898.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/3/2026ACC: 0001842190-26-000009
Director
Since Dec 2021
-11.58K
Net shares
Net seller
$898.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
11.58K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.60K
Price / share
$73.86
Trade value
$339.83K
% of position
19.7%
9/1/2026
23.31K→18.71K
Common Stock
Direct
Shares
−5.39K
Price / share
$80.00
Trade value
$430.96K
% of position
28.8%
9/2/2026
18.71K→13.32K
Common Stock
Indirect
Shares
−1.59K
Price / share
$80.00
Trade value
$127.20K
% of position
25.0%
9/2/2026
6.36K→4.77K
Total
Net shares
−11.58K
Net value
-$897.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −4.60K | $73.86 | $339.83K | 19.7% | 23.31K | 18.71K |
| Common Stock Direct | 9/2/2026 | S · Sale | −5.39K | $80.00 | $430.96K | 28.8% | 18.71K | 13.32K |
| Common Stock Indirect | 9/2/2026 | S · Sale | −1.59K | $80.00 | $127.20K | 25.0% | 6.36K | 4.77K |
| Total | −11.58K | -$897.99K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned12.04K
Total
12.04K indirect12.04K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.04K | Indirect |
| Total | 12.04K | 12.04K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported